End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
589.4 INR | +0.42% | +1.73% | +10.22% |
Summary
- The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 64% by 2026.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 39.97 times its estimated earnings per share for the ongoing year.
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.22% | 4.11B | C- | ||
+8.51% | 77.31B | B- | ||
+13.39% | 53.05B | B | ||
+14.41% | 52.93B | B+ | ||
+24.86% | 48.37B | B+ | ||
+21.99% | 45.08B | B+ | ||
+22.43% | 39.43B | B | ||
+18.80% | 33.46B | B | ||
+42.95% | 29.24B | A | ||
+1.02% | 29.21B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- STARHEALTH Stock
- Ratings Star Health and Allied Insurance Company Limited